Skip to menu Skip to content Skip to footer

2011

Journal Article

No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome: Should the recently published PCOS guidelines be revised?

Inder, Warrick J. (2011). No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome: Should the recently published PCOS guidelines be revised?. Medical Journal of Australia, 195 (10), 578-579. doi: 10.5694/mja11.11307

No evidence of benefit for universal screening with 75 g oral glucose tolerance test in polycystic ovary syndrome: Should the recently published PCOS guidelines be revised?

2011

Journal Article

Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle

La Gerche, Andre, Heidbuechel, Hein, Burns, Andrew T., Mooney, Don J., Taylor, Andrew J., Pfluger, Heinz B., Inder, Warrick J., Macisaac, Andrew I. and Prior, David L. (2011). Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle. Medicine and Science in Sports and Exercise, 43 (6), 974-981. doi: 10.1249/MSS.0b013e31820607a3

Disproportionate Exercise Load and Remodeling of the Athlete's Right Ventricle

2010

Journal Article

Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise

La Gerche, Andre, MacIsaac, Andrew I., Burns, Andrew T., Mooney, Don J., Inder, Warrick J., Voigt, Jens-Uwe, Heidbuchel, Hein and Prior, David L. (2010). Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise. Journal of Applied Physiology, 109 (5), 1307-1317. doi: 10.1152/japplphysiol.00457.2010

Pulmonary transit of agitated contrast is associated with enhanced pulmonary vascular reserve and right ventricular function during exercise

2010

Journal Article

Acidosis in the hospital setting – is metformin a common precipitant?

Scott, Katherine A., Martin, Jennifer H. and Inder, Warrick J. (2010). Acidosis in the hospital setting – is metformin a common precipitant?. Internal Medicine Journal, 40 (5), 342-346. doi: 10.1111/j.1445-5994.2009.01959.x

Acidosis in the hospital setting – is metformin a common precipitant?

2009

Journal Article

Skeletal muscle 11β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery

Jang, Christina, Obeyesekere, Varuni R., Alford, Frank P. and Inder, Warrick J. (2009). Skeletal muscle 11β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery. European Journal of Endocrinology, 160 (2), 249-255. doi: 10.1530/EJE-08-0619

Skeletal muscle 11β hydroxysteroid dehydrogenase type 1 activity is upregulated following elective abdominal surgery

2008

Journal Article

Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone

Jang, Christina, Inder, Warrick J., Obeyesekere, Varuni R. and Alford, Frank P. (2008). Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone. Clinical Endocrinology, 69 (5), 745-750. doi: 10.1111/j.1365-2265.2008.03242.x

Adiponectin, skeletal muscle adiponectin receptor expression and insulin resistance following dexamethasone

2005

Journal Article

Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment

Inder, WJ, Prickett, TCR and Mulder, RT (2005). Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment. Clinical Endocrinology, 62 (3), 343-348. doi: 10.1111/j.1365-2265.2005.02220.x

Normal opioid tone and hypothalamic-pituitary-adrenal axis function in chronic fatigue syndrome despite marked functional impairment

2004

Journal Article

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]

Barter, P., Best, J., Colman, P., d'Emden, M., Davis, T., Drury, P., Ehnholm, C., Glasziou, P., Hunt, D., Keech, A., Kesaniemi, Y. A., Laakso, M., Scott, R., Simes, R. J., Sullivan, D., Taskinen, M-R, Whiting, M., Ansquer, J-C, Fraitag, B., Anderson, N., Hankey, G., Hunt, D., Lehto, S., Mann, S., Romo, M., Li, L. P., Hennekens, C., MacMahon, S., Pocock, S. ... Aubonnet, P. (2004). The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]. Cardiovascular Diabetology, 3 (1) 9. doi: 10.1186/1475-2840-3-9

The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]